Globitair

India orders top drugmaker to halt eye medicine production at plant over quality lapses

CNAIndia

India orders top drugmaker to halt eye medicine production at plant over quality lapses

Indian regulators have escalated action against India's largest drugmaker, Sun Pharma, barring ophthalmic drug production at its Assam factory until it submits a satisfactory compliance report.

Read the full story at CNAOpen in the live monitor

Related discussion groups

No group discusses this yet. Start a discussion group and attach this story.

More news about India